Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 131,730 | reported | 27 Feb 2026 | tx 150+478,454−397,563 |
| Ginkgo Bioworks Holdings, Inc. | 0 | reported | 12 Jun 2024 | tx 11+618,890−115,081 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 3,278 | 488.27 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,510 | 487.13 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 240 | 482.84 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 120 | 481.50 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 400 | 479.75 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 460 | 489.32 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,725 | 496.95 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 5,995 | 496.16 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,725 | 490.54 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 949 | 491.30 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,520 | 493.29 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 3,498 | 494.33 USD | |
| 27 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 15,580 | 495.38 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 4,981 | 485.11 USD | |
| 17 Feb 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 16,326 | 0.00 USD | |
| 17 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 6,554 | 483.75 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 13,041 | 487.76 USD | |
| 10 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 8,297 | 468.41 USD | |
| 22 Jan 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 26,972 | 0.00 USD | |
| 22 Jan 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 11,885 | 0.00 USD | |
| 06 Aug 2025 | PURCHASE | VERTEX PHARMACEUTICALS INC / MA | 4,290 | 389.08 USD | first after silence |
| 06 Aug 2025 | PURCHASE | VERTEX PHARMACEUTICALS INC / MA | 5,710 | 389.95 USD | |
| 26 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 14,079 | 479.61 USD | |
| 24 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 9,386 | 483.28 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 6,553 | 463.46 USD |
1 purchase reported after at least 12 months of silence — most recent on 06 Aug 2025.